Eosinophilic dermatoses;Eosinophile dermatosen

Hautarzt

Volumn 58, Issue 4, 2007, Pages 347-360

  Wozel, G ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Eosinophilia; Eosinophilic dermatoses; Eosinophilic granulocyte; Hypereosinophilic syndrome; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALEMTUZUMAB; ALLOPURINOL; ALPHA INTERFERON; AZATHIOPRINE; BENZATHINE PENICILLIN; BLEOMYCIN; CARBAMAZEPINE; CLOFAZIMINE; COTRIMOXAZOLE; CYCLOSPORIN A; DAPSONE; ETRETIN; FLUOROURACIL; GLUCOCORTICOID; HYDROXYUREA; IMMUNOGLOBULIN; INDOMETACIN; ISONIAZID; ISOTRETINOIN; MEPOLIZUMAB; METHOTREXATE; METRONIDAZOLE; MINOCYCLINE; PENICILLAMINE; PERMETHRIN; PREDNISOLONE; SCH 55700; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIONEUROTIC EDEMA; ATOPIC DERMATITIS; CELL ADHESION; CELL COMPOSITION; CELL FUNCTION; CELL STRUCTURE; CHRONIC GRANULOMATOUS DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC FASCIITIS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTIOCYTOSIS X; HUMAN; HYPEREOSINOPHILIC SYNDROME; HYPERGAMMAGLOBULINEMIA; IMMUNE RESPONSE; IMMUNITY; MONOTHERAPY; NONHUMAN; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TARGET ORGAN; WELLS SYNDROME;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; EOSINOPHILIA; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; SKIN DISEASES;

EID: 34247236104     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1318-9     Document Type: Review

References (26)

1. Antic M, Lautenschlager S, Itin PH (2006) Eosinophilic fasciitis 30 years after - What do we really know? Dermatology 213: 93-101
2. Azouz EM, Saigal G, Rodriguez MM, Podda A (2005) Langerhans' cell histiocytosis: pathology, imaging and treatment of skeletal involvement. Pediatr Radiol 35: 103-115
3. Boura P, Sarantopoulos A, Lefaki I et al. (2006) Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab. Ann Rheum Dis 65: 839-840
4. Chong WS, Thomas A, Goh CL (2006) Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two disease entities in the same patient. Case report and review of the literature. Int J Dermatol 45: 139-145
5. Cools J, DeAngelo DJ, Gotlib J et al. (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes is a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348: 1201-1214
6. DeWitt CA, Bishop AB, Buescher LS, Stone SP (2006) Hyperimmunglobulin E syndrome: two cases and a review of the literature. J Am Acad Dermatol 54: 855-865
7. Ellis E, Scheinfeld N (2004) Eosinophilic pustular folliculitis - a comprehensive review of treatment options. Am J Clin Dermatol 5: 189-197
8. Fletcher S, Bain B (2007) Diagnosis and treatment of hypereosinophilic syndromes. Curr Opin Hematol 14: 37-42
9. Gleich GJ, Adolphson CR, Leiferman KM (1992) Eosinophils. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation - basic principles and clinical correlates, 2nd edn. Raven Press, New York, pp 663-700
10. Gotlib J, Cools J, Malone JM et al. (2004) The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukaemia: implications for diagnosis, classification, and management. Blood 103: 2879-2891
11. Gotlib J, Cross NCP, Gilliland DG (2006) Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy. Best Pract Res Clin Haematol 19: 535-569
12. Grimbacher B, Holland SM, Puck JM (2005) Hyper-IgE syndromes. Immunol Rev 203: 244-250
13. Imanka A, Tarutani M, Itoh H et al. (2004) Langerhans cell histiocytosis involving the skin of an elderly woman: a satisfactory remission with oral prednisolone alone. J Dermatol 31: 1023-1026
14. Klion AD, Law MA, Noel P et al. (2004) Safety and efficacy of the monoclonal anti-interleukin-5 antibody SCH55700 in the treatment of patients with hypereosinophilic syndrome. Blood 103: 2939-2941
15. Liesveld JL, Abboud CN (1991) State of the art: hypereosinophilic syndromes. Blood 5: 29-37
16. Moossavi M, Mehregan DR (2003) Wells' syndrome: a clinical and histopathologic review of seven cases. Int J Dermatol 42: 62-67
17. Peters MS, Schroeter AL, Gleich GJ (1983) Immunofluorescence identification of eosinophil granule major basic protein in the flame figures of Wells' syndrome. Br J Dermatol 109: 141-148
18. Sefcick A, Sowter D, DasGupta E et al. (2004) Alemtuzumab therapy for refractory hypereosinophilic syndrome. Br J Haematol 124: 558-559
19. Simon D, Braathen LR, Simon HU (2005) Anti-interleukin-5 antibody therapy in eosinophilic diseases. Pathobiol 72: 287-292
20. Szeimies RM, Meurer M (1993) Tryptophan-assoziiertes Eosinophilie- Myalgie-Syndrom. Dtsch Med Wochenschr 118: 213-220
21. Tefferi A (2005) Modern diagnosis and treatment of primary eosinophilia. Acta Haematol 114: 52-60
22. Tefferi A, Patnaik M, Pardanani A (2006) Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 133: 468-492
23. Teixeira MM, Williams TJ, Hellewell PG (1995) Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. TiPS 16: 418-423
24. Wilkins HJ, Crane MM, Copeland K, Williams WV (2005) Hypereosinophilic syndrome: an update. Am J Haematol 80: 148-157
25. Wozel G (1996) Dapson - Pharmakologie, Wirkmechanismus und klinischer Einsatz. Georg Thieme, Stuttgart New York
26. Ziemer M, Böer A (2005) Eosinophilic pustular folliculitis in infancy - not a distinctive inflammatory disease of the skin. Am J Dermatopathol 27: 443-455